BioCentury
ARTICLE | Company News

Astellas sales and marketing update

April 15, 2013 7:00 AM UTC

Astellas' Astellas Pharma Canada Inc. subsidiary launched Myrbetriq mirabegron in Canada to treat overactive bladder (OAB) with symptoms of urgency, urgency incontinence and urinary frequency. The wh...